- Home
- HIMS
as 03-28-2025 4:00pm EST
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | SAN FRANCISCO |
| Market Cap: | 9.0B | IPO Year: | N/A |
| Target Price: | $38.75 | AVG Volume (30 days): | 22.5M |
| Analyst Decision: | Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.53 | EPS Growth: | N/A |
| 52 Week Low/High: | $11.20 - $72.98 | Next Earning Date: | 05-05-2025 |
| Revenue: | $1,476,514,000 | Revenue Growth: | 69.33% |
| Revenue Growth (this year): | 56.79% | Revenue Growth (next year): | 18.10% |
Stock Insider Trading Activity of Hims & Hers Health Inc. (HIMS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Baird Melissa | HIMS | Chief Operating Officer | Mar 26 '25 | Sell | $35.48 | 67,687 | $2,358,144.87 | 751,243 | |
| Dudum Andrew | HIMS | Chief Executive Officer | Mar 14 '25 | Sell | $33.62 | 254,421 | $8,618,493.25 | 387,349 | |
| Carroll Patrick Harrison | HIMS | Chief Medical Officer | Mar 14 '25 | Sell | $34.31 | 23,287 | $798,976.97 | 209,661 | |
| Becklund Irene | HIMS | PAO | Mar 3 '25 | Sell | $45.14 | 2,913 | $131,492.82 | 4,406 | |
| Chi Michael | HIMS | Chief Commercial Officer | Feb 24 '25 | Sell | $48.14 | 17,303 | $832,966.42 | 193,601 | |
| Chi Michael | HIMS | Chief Commercial Officer | Feb 19 '25 | Sell | $59.26 | 7,500 | $444,450.00 | 193,601 | |
| Dudum Andrew | HIMS | Chief Executive Officer | Feb 18 '25 | Sell | $58.67 | 175,661 | $10,230,063.10 | 387,349 | |
| Boughton Soleil | HIMS | Chief Legal Officer | Feb 18 '25 | Sell | $60.69 | 4,152 | $251,984.88 | 157,345 | |
| Baird Melissa | HIMS | Chief Operating Officer | Feb 12 '25 | Sell | $44.86 | 67,687 | $3,026,624.14 | 751,243 | |
| Okupe Oluyemi | HIMS | Chief Financial Officer | Feb 10 '25 | Sell | $43.13 | 11,581 | $498,100.46 | 107,789 |
Latest Hims & Hers Health Inc. News
HIMS Breaking Stock News: Dive into HIMS Ticker-Specific Updates for Smart Investing
Argus Research
3 days ago
HIMS: Raising target price to $42.00
The Wall Street Journal
9 days ago
Sale of Ozempic Knockoffs Is Supposed to End Soon. Telehealth Companies Aren’t Happy.
The Wall Street Journal
16 days ago
They Wanted a Quick Fix for Hair Loss. Instead, These Young Men Got Sick.
GlobeNewswire
16 days ago
Defiance Launches RKLX and HIMZ: 2X Leveraged ETFs for Rocket Lab and Hims & Hers
PR Newswire
18 days ago
Define Ventures Appoints Carolyn Magill as Venture Partner
Yahoo Finance
22 days ago
Walgreens stock rises amid $10 billion deal with Sycamore Partners to take the drugstore chain private
Investor's Business Daily
23 days ago
Hims Stock Claws Back After Novo Nordisk Undercuts It With A Cheaper Wegovy
Schaeffer's Investment Research
23 days ago
Healthcare Stock Could Be Good 'Buy the Dip' Play
Compare HIMS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HIMS Hims & Hers Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.